Form 4 for KYTX Kyverna Therapeutics, Inc.
Accepted 2026-03-04 00:00:00 ET · period of report 2026-02-24 · accession 0001193125-26-091626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-04 | 2026-02-24 | KYTX | Miller Andrew Craig | Dir | A - Grant | $0.00 | +11.0K | 11.0K | New | $0 |
| D | 2026-03-04 | 2026-02-24 | KYTX | Miller Andrew Craig | Dir | A - Grant | $0.00 | +42.9K | 42.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | A | A | 11,006 | $0.00 | 11,006 | D | — | — | (F1) Represents a restricted stock unit award of common stock and 1/3rd of the shares underlying the restricted stock unit award shall vest on each one-year anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. |
| 2 | Derivative | Stock Option (right to buy) | 2026-02-24 | A | A | 42,945 | $0.00 | 42,945 | D | $7.95 · — to 2036-02-24 | 42,945 Common Stock | (F2) 1/36th of the shares subject to the option shall vest on each monthly anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. |